Andrew Feldman, CEO of Cerebras, says there's tremendous demand from every AI company for DeepSeek's efficient open-source ...

The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...

Cerebras is another rising technology company looking to go public with an estimated valuation of $4.3 billion. The company, which operates in the AI-optimized semiconductor space, was expected to ...

Rheumatoid arthritis is a crippling condition affecting 1.3 million people. To date, the standard of care has been to head off the progression of inflammation through trial-and-error treatment with a ...

Cerebras Systems, in collaboration with Mayo Clinic, announced significant progress in developing artificial intelligence tools to advance patient care, today at the JP Morgan Healthcare Conference in ...

ROCHESTER, Minn. & SUNNYVALE, Calif., January 14, 2025--(BUSINESS WIRE)--Cerebras Systems, in collaboration with Mayo Clinic, announced significant progress in developing artificial intelligence tools ...

Cerebras Systems (a client of Cambrian-AI Research) announced a new foundation model co-developed with partner The Mayo Clinic, that can identify the best medical therapy for Rheumatoid Arthritis.

In what Branson calls “inference wars,” AI infrastructure companies — such as Cerebras, Groq and SambaNova — compete to deliver hardware breakthroughs that enhance token throughput ...

Cerebras Systems, in collaboration with Mayo Clinic, announced significant progress in developing artificial intelligence tools to advance patient care, today at the JP Morgan Healthcare ...